Platform Technology Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Platform Technology Partners's NVO Position: Q2 2026 in Review
Platform Technology Partners increased its Novo Nordisk (NVO) stake by 39% in Q2 2026, buying an estimated $132K and bringing the position to 10,941 shares worth $525K. The position accounts for 0.09% of the portfolio, ranked #179.
Platform Technology Partners first reported a position in NVO in Q4 2019 and has held it in 24 quarters since. The position peaked at $593K in Q3 2021. 1,357 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Platform Technology Partners held 10,941 shares of Novo Nordisk worth $525K as of Q2 2026.
- Platform Technology Partners bought 3,079 Novo Nordisk shares in Q2 2026, an estimated $132K.
- Novo Nordisk made up 0.09% of Platform Technology Partners's portfolio in Q2 2026, its #179 holding.
- Platform Technology Partners first reported a position in Novo Nordisk in Q4 2019 and has held it in 24 quarters since.
- Platform Technology Partners's Novo Nordisk position peaked at $593K in Q3 2021.
- 1,357 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.